Ishita Roy

Delhi Air Pollution Is Also Causing Digestive Health Issues

Relationship between pollution and gut health

It is not hidden anymore that the rise in <span>pollution</span> is leading to an increasing concern because of its negative influence on human health. A new peer-reviewed study published in the BMJ Journal shows that particulate matter from environmental pollution causes stomach problems.

<h4>How Does Pollution Impact the Digestive System?</h4>

The digestive system is critical for breaking down food and absorbing nutrients, but it is also vulnerable to the harmful effects of environmental pollutants. Pollutants such as heavy metals, pesticides, and industrial pollutants can taint food and cause stomach issues. These pollutants can disrupt the gut microbiota balance, impair nutritional absorption, and increase the likelihood of developing digestive issues.

Stress responses have a significant impact on the onset and course of digestive disorders. Pollution and other environmental disturbances trigger a series of physiological and biochemical responses. Chronic pollution-induced stress can produce inflammation, oxidative stress, and immunological dysfunction in the digestive system, contributing to conditions like irritable bowel syndrome, inflammatory bowel disease, and gastroesophageal reflux.

Research investigations have found a strong link between pollution exposure and the development of digestive diseases. Environmental pollution, including air and <span>water pollution</span>, has a direct impact on generating stress responses in the digestive tract, resulting in a variety of digestive illnesses.

A number of studies have investigated the link between pollution exposure and digestive diseases. For example, a study published in the Journal of Gastrointestinal and Liver Diseases discovered that those who lived in heavily polluted locations had a greater prevalence of gastrointestinal diseases like IBS and IBD.

According to the Central Pollution Control Board (CPCB), Delhi's average air quality index (AQI) stood at 358 as of 7:30 am.

The AQI surpassed 400, marking 'severe' levels in areas like Bawana (412), Mundka (419), NSIT Dwarka (447), and Wazirpur (421).

<ul><li>Individuals with pre-existing gastrointestinal conditions</li><li>Children</li><li>Elderly</li><li>Those with compromised immune function</li></ul>

<h4>Types Of Pollution And Its Impact</h4>

Air pollution is a key contributor to environmental damage, and it can also have a negative impact on your overall health as well as your <span>digestive health</span>. Pollutants such as particulate matter, volatile organic compounds (VOCs), and nitrogen dioxide (NO2) can cause inflammation in the gastrointestinal tract, interfering with normal function. Chronic exposure to air pollution has been related to an increased risk of digestive illnesses such as GERD and IBD.

Water contamination is another major issue for the digestive system. Heavy metals, herbicides, and microbiological infections can contaminate the water supply, endangering human health. Consuming contaminated water can cause gastrointestinal infections, diarrhoea, and chronic illnesses such as liver damage and colon cancer.

Chemical pollutants such as industrial chemicals, pesticides, and food additives have been related to a wide range of digestive disorders. Exposure to these chemicals through contaminated food, air, or water can disrupt the gut microbial balance, leading to disorders like irritable bowel syndrome (IBS), food intolerances, and colon cancer.

Stress response in digestive diseases. Stress has a huge impact on your whole health, particularly the digestive system. There are mechanisms by which stress causes responses in digestive disorders. Stress hormones, inflammation, and oxidative stress all have an effect on your gut microbiota, which is a natural ecosystem in your body that serves several functions, including defending you from harmful germs.

Health Conditions A-Z

health

delhi air pollution

delhi pollution

gut health

digestive health

delhi smog

respiratory health

water pollution

pollution

Nine-month-old Child Tested Positive For Covid-19 In Bengaluru

Postpartum Psychosis Is 10 Times More Likely For Women With Family Link To The Condition

Easy Ways To Control Your Blood Sugar And Morning Cravings

Health News

How Do You Calorie Count – Numbers And Nutrients

Unexpected Signs Of Dehydration – Safety And Precaution Measures

Leg Exercises You Can Do At Home To Build Strength

Foods That Promote Skin Elasticity

Must-Do Chest Exercises You Can Try At Home

What Are The Symptoms Of JN.1 COVID-19 Strain?

Why Does Sleeping Become Harder As You Age?

High-Fiber Healthy Drinks You Should Try

10 Dumbbell Exercise Variations For Upper-Body Strength

A Parent’s Guide To Pets: Important Points To Consider For Your Child’s Health

Food Anxiety Is Real – How Your Food Intake Affects Your Anxiety

World Osteoporosis Month: Ways To Strengthen Your Bones

Brain Exercises To Keep You Cognitively Sharp

Easy Recipes To Make When You Don’t Wish To Cook

Physical Signs Of High Cortisol

9 Healthy Plant-Based Protein Rich Dishes To Try

What Happens When You Have Low Blood Pressure?

Throw These Toxic Bathroom Items Away To Protect Your Health

This Is What Cricket Superstar Virat Kohli Eats In A Day

Signs You Are Experiencing Sensory Overload

Shoulder Exercises You Should Do For Defined Shoulders

Best Foods To Eat When You Are Fasting

​Ghee For Ayurveda: Why It Should Be A Part Of Your Diet​

Symptoms Of Ovarian Cancer You Should Know

Yoga Poses That Can Build Core Strength

Biotin-Rich Foods You Should Add To Your Diet

Unexpected Physical Signs Of Stress

Simple And Affective Guide To Stop A Panic Attack

Signs Of Heat Exhaustion In Children

10 Heart Symptoms You Shouldn't Ignore

Lower Your Cholesterol With These Foods

Food Myths You Should Stop Believing

Work Stressing You Out? Tips To Handle Toxic Workspaces

Looking To Gain Weight? High-Calorie Healthy Foods To Try

​Pomegranates Are A Must For Summer, Here’s Why​

​How Does Being A Night Owl Change Your Brain​

​Can Nightlights Affect Your Child’s Sleep​

How To Decide Whether You Should Do Cardio Or Strength Training?

Enjoying Hobbies As An Adult Is More Important Than You Realize

Screentime Matters For Parents Too, Here's How It Causes Issues

It is not hidden anymore that the rise in pollution is leading to an increasing concern because of its negative influence on human health. A new peer-reviewed study published in the BMJ Journal shows that particulate matter from environmental pollution causes stomach problems.How Does Pollution Impact the Digestive System?The digestive system is critical for breaking down food and absorbing nutrients, but it is also vulnerable to the harmful effects of environmental pollutants. Pollutants such as heavy metals, pesticides, and industrial pollutants can taint food and cause stomach issues. These pollutants can disrupt the gut microbiota balance, impair nutritional absorption, and increase the likelihood of developing digestive issues.Stress responses have a significant impact on the onset and course of digestive disorders. Pollution and other environmental disturbances trigger a series of physiological and biochemical responses. Chronic pollution-induced stress can produce inflammation, oxidative stress, and immunological dysfunction in the digestive system, contributing to conditions like irritable bowel syndrome, inflammatory bowel disease, and gastroesophageal reflux.Research investigations have found a strong link between pollution exposure and the development of digestive diseases. Environmental pollution, including air and water pollution, has a direct impact on generating stress responses in the digestive tract, resulting in a variety of digestive illnesses.A number of studies have investigated the link between pollution exposure and digestive diseases. For example, a study published in the Journal of Gastrointestinal and Liver Diseases discovered that those who lived in heavily polluted locations had a greater prevalence of gastrointestinal diseases like IBS and IBD.Who Are At Risk?According to the Central Pollution Control Board (CPCB), Delhi's average air quality index (AQI) stood at 358 as of 7:30 am.The AQI surpassed 400, marking 'severe' levels in areas like Bawana (412), Mundka (419), NSIT Dwarka (447), and Wazirpur (421).Individuals with pre-existing gastrointestinal conditionsChildrenElderlyThose with compromised immune functionTypes Of Pollution And Its ImpactAir pollution is a key contributor to environmental damage, and it can also have a negative impact on your overall health as well as your digestive health. Pollutants such as particulate matter, volatile organic compounds (VOCs), and nitrogen dioxide (NO2) can cause inflammation in the gastrointestinal tract, interfering with normal function. Chronic exposure to air pollution has been related to an increased risk of digestive illnesses such as GERD and IBD.Water contamination is another major issue for the digestive system. Heavy metals, herbicides, and microbiological infections can contaminate the water supply, endangering human health. Consuming contaminated water can cause gastrointestinal infections, diarrhoea, and chronic illnesses such as liver damage and colon cancer.Chemical pollutants such as industrial chemicals, pesticides, and food additives have been related to a wide range of digestive disorders. Exposure to these chemicals through contaminated food, air, or water can disrupt the gut microbial balance, leading to disorders like irritable bowel syndrome (IBS), food intolerances, and colon cancer.Stress response in digestive diseases. Stress has a huge impact on your whole health, particularly the digestive system. There are mechanisms by which stress causes responses in digestive disorders. Stress hormones, inflammation, and oxidative stress all have an effect on your gut microbiota, which is a natural ecosystem in your body that serves several functions, including defending you from harmful germs.

delhi air pollution is also causing digestive health issues

Health and Me

23 New Covid Cases In Delhi, Health Minister Issues Advisory

23 new covid cases in delhi, health minister issues advisory

India Logs Rise In New Covid Cases: Here's All You Need To Know

india logs rise in new covid cases: here's all you need to know

New COVID Variant NB.1.8.1 Has Been Circulating Across US Since March, Officials Confirm

new covid variant nb.1.8.1 has been circulating across us since march, officials confirm

10 Things About The New COVID-19 Vaccine Plan By Trump Administration

10 things about the new covid-19 vaccine plan by trump administration

A nine-month-old baby boy from Hoskote in Bengaluru Rural district has tested positive for <span>Covid-19</span>, according to Karnataka’s Health and Family Welfare Department. The infant was initially taken to a private hospital but later transferred to Vani Vilas Hospital in Kalasipalya, Bengaluru, for specialized care.

The child tested positive through a Rapid Antigen Test conducted on May 22. Officials confirmed that the baby is in stable condition and under close medical observation. Doctors at the hospital say he is responding well to treatment.

The case comes at a time when Karnataka is witnessing a slight but noticeable increase in Covid-19 cases. As of now, the state has 35 active infections, with 32 of them reported in Bengaluru alone. So far, no fatalities have been linked to the recent surge.

Health authorities noted a gradual uptick in cases over the last 20 days, prompting reminders to the public to follow <span>Covid</span> safety protocols. People have been advised to wear masks in crowded places, maintain hygiene, and avoid unnecessary gatherings—particularly in cities like Bengaluru, where the majority of cases are being reported.

Neighbouring Kerala has experienced a sharper rise in infections this month, with 182 confirmed cases so far. The state’s Health Minister has urged residents to remain alert and take precautionary measures. Among the districts, Kottayam has recorded the highest number of infections (57), followed by Ernakulam (34) and Thiruvananthapuram (30).

In response, Kerala’s health authorities have stepped up public messaging to promote early testing and isolation to limit the spread of the virus.

<strong>ALSO READ: <a href="https://www.healthandme.com/health-news/23-new-covid-cases-in-delhi-health-minister-issues-advisory-article-151706605" data-type="tilCustomLink">23 New Covid Cases In Delhi, Health Minister Issues Advisory</a></strong>

<h4>Andhra Pradesh Issues Public Advisory</h4>

In Andhra Pradesh, the Health Department released a public advisory on May 22 following indications of a rise in Covid-19 cases. Although specific figures have not been released, officials have recommended that people stay cautious, get tested if they show symptoms, and continue following preventive practices such as masking and hand hygiene.

In an internal order, Delhi’s health department directed all hospitals to ensure critical equipment like ventilators, BiPAP machines, and oxygen concentrators are functional. Staff are being asked to undergo refresher training, and all hospitals must report Influenza-like Illness (ILI) and Severe Acute Respiratory Illness (SARI) cases daily on the Integrated Health Information Platform (IHIP).

Additionally, 5% of ILI cases and 100% of SARI cases must undergo COVID-19 testing, in accordance with ICMR guidelines. Positive samples are to be sent to Lok Nayak Hospital for genome sequencing to detect any emerging variants.

<h4>Cases Originally From Singapore And Hong Kong</h4>

Singapore and Hong Kong are witnessing a noticeable surge in COVID-19 cases, primarily driven by LF.7 and NB.1.8 sub-variants. Singapore’s Ministry of Health has urged citizens to get vaccinated, especially those who haven’t received their initial doses. Hong Kong has reached its highest case numbers in over a year and is encouraging mask-wearing and crowd avoidance.

Unlike earlier variants, the current wave presents some slightly different symptoms. While cough and sore throat remain common, additional symptoms include nausea, vomiting, brain fog, and conjunctivitis. Most cases are mild, but health authorities advise individuals to monitor symptoms and seek medical attention if needed.

covid

9-year boy tested positive for covid

health news

health news india

covid-19 news

covid 19

covid-19

A nine-month-old baby boy from Hoskote in Bengaluru Rural district has tested positive for Covid-19, according to Karnataka’s Health and Family Welfare Department. The infant was initially taken to a private hospital but later transferred to Vani Vilas Hospital in Kalasipalya, Bengaluru, for specialized care.The child tested positive through a Rapid Antigen Test conducted on May 22. Officials confirmed that the baby is in stable condition and under close medical observation. Doctors at the hospital say he is responding well to treatment.Covid-19 Situation in KarnatakaThe case comes at a time when Karnataka is witnessing a slight but noticeable increase in Covid-19 cases. As of now, the state has 35 active infections, with 32 of them reported in Bengaluru alone. So far, no fatalities have been linked to the recent surge.Health authorities noted a gradual uptick in cases over the last 20 days, prompting reminders to the public to follow Covid safety protocols. People have been advised to wear masks in crowded places, maintain hygiene, and avoid unnecessary gatherings—particularly in cities like Bengaluru, where the majority of cases are being reported.Rise in Cases in KeralaNeighbouring Kerala has experienced a sharper rise in infections this month, with 182 confirmed cases so far. The state’s Health Minister has urged residents to remain alert and take precautionary measures. Among the districts, Kottayam has recorded the highest number of infections (57), followed by Ernakulam (34) and Thiruvananthapuram (30).In response, Kerala’s health authorities have stepped up public messaging to promote early testing and isolation to limit the spread of the virus.ALSO READ: 23 New Covid Cases In Delhi, Health Minister Issues AdvisoryAndhra Pradesh Issues Public AdvisoryIn Andhra Pradesh, the Health Department released a public advisory on May 22 following indications of a rise in Covid-19 cases. Although specific figures have not been released, officials have recommended that people stay cautious, get tested if they show symptoms, and continue following preventive practices such as masking and hand hygiene.Advisory For Delhi HospitalsIn an internal order, Delhi’s health department directed all hospitals to ensure critical equipment like ventilators, BiPAP machines, and oxygen concentrators are functional. Staff are being asked to undergo refresher training, and all hospitals must report Influenza-like Illness (ILI) and Severe Acute Respiratory Illness (SARI) cases daily on the Integrated Health Information Platform (IHIP).Additionally, 5% of ILI cases and 100% of SARI cases must undergo COVID-19 testing, in accordance with ICMR guidelines. Positive samples are to be sent to Lok Nayak Hospital for genome sequencing to detect any emerging variants.Cases Originally From Singapore And Hong KongSingapore and Hong Kong are witnessing a noticeable surge in COVID-19 cases, primarily driven by LF.7 and NB.1.8 sub-variants. Singapore’s Ministry of Health has urged citizens to get vaccinated, especially those who haven’t received their initial doses. Hong Kong has reached its highest case numbers in over a year and is encouraging mask-wearing and crowd avoidance.What Are the Current Symptoms?Unlike earlier variants, the current wave presents some slightly different symptoms. While cough and sore throat remain common, additional symptoms include nausea, vomiting, brain fog, and conjunctivitis. Most cases are mild, but health authorities advise individuals to monitor symptoms and seek medical attention if needed.

nine-month-old child tested positive for covid-19 in bengaluru

New Delhi is witnessing a modest increase in <span>COVID-19</span> cases, with 23 active infections reported as of May 22, Health Minister Dr. Pankaj Singh confirmed on Friday. Emphasizing that there is no reason to panic, Singh said all patients are currently stable. “Two to three patients are admitted to private hospitals while the others are being monitored. We will verify if these patients are residents of Delhi or from outside. The strain is similar to influenza,” he noted.

The minister also reassured the public about the state’s preparedness. “We’ve had conversations with medical superintendents. Eight senior officials are visiting hospitals daily to ensure everything is in order. Our hospitals are equipped with oxygen, oximeters, and essential medical supplies,” Singh added.

In line with this, the Delhi health department has instructed all private and government hospitals to ensure the availability of beds, oxygen, essential medicines, and vaccines. An advisory will be issued shortly to provide further guidance.

<h4>Omicron Sub-Variants Fuel Regional and Global Spike</h4>

The rise in COVID-19 cases in Delhi and other Indian states comes after a spike was observed in several Asian countries. Health authorities have attributed the increase to Omicron-related sub-variants—primarily LF.7 and NB.1.8—descendants of the JN.1 variant, which in turn evolved from the BA.2.86 (Pirola) strain.

These sub-lineages are known for their high transmissibility but relatively mild symptoms. Despite the rise, experts maintain that the current wave is manageable and no immediate threat of severe disease has been identified.

<h4>Neighboring States And Others Also Report Mild Cases</h4>

Haryana: Two mild COVID-19 cases were reported in Gurgaon—a 62-year-old man and a 31-year-old woman who had recently travelled from Mumbai. Both are in home isolation. Meanwhile, a 28-year-old security guard from Faridabad tested positive at Delhi’s Safdarjung Hospital. None had a travel history abroad or known contact with infected persons. Health officials emphasized that these are isolated, mild cases and do not indicate a severe outbreak.

Maharashtra: The state has reported 95 new COVID-19 cases in Mumbai this month, with a total of 106 since January. At least 16 patients are hospitalized, mostly shifted to Seven Hills Hospital from KEM Hospital. Pune, although not reporting any active cases currently, has reserved 50 beds at Naidu Hospital as a precautionary step.

<strong>Tamil Nadu:</strong> In Chennai and Puducherry, health officials are seeing a shift in viral diagnosis, where fevers initially linked to influenza are now being identified as COVID-19. Public Health Director Dr. TS Selvavinayagam has urged caution in crowded places but reassured the public not to panic.

<strong>Karnataka: </strong>The state currently has 16 active COVID-19 cases, confirmed by Health Minister Dinesh Gundu Rao.

<strong>Gujarat: </strong>Seven new cases were reported in Ahmedabad in a single day—a sharp spike for a city that has averaged one case per month over the past year. All patients are in home isolation, and their samples have been sent for genomic sequencing. Officials say the infections are from the JN.1 variant and are mild in nature.

covid 19 news

covid 19 Delhi

Delhi covid 19 cases

delhi health news

india health news

New Delhi is witnessing a modest increase in COVID-19 cases, with 23 active infections reported as of May 22, Health Minister Dr. Pankaj Singh confirmed on Friday. Emphasizing that there is no reason to panic, Singh said all patients are currently stable. “Two to three patients are admitted to private hospitals while the others are being monitored. We will verify if these patients are residents of Delhi or from outside. The strain is similar to influenza,” he noted.The minister also reassured the public about the state’s preparedness. “We’ve had conversations with medical superintendents. Eight senior officials are visiting hospitals daily to ensure everything is in order. Our hospitals are equipped with oxygen, oximeters, and essential medical supplies,” Singh added.In line with this, the Delhi health department has instructed all private and government hospitals to ensure the availability of beds, oxygen, essential medicines, and vaccines. An advisory will be issued shortly to provide further guidance.Omicron Sub-Variants Fuel Regional and Global SpikeThe rise in COVID-19 cases in Delhi and other Indian states comes after a spike was observed in several Asian countries. Health authorities have attributed the increase to Omicron-related sub-variants—primarily LF.7 and NB.1.8—descendants of the JN.1 variant, which in turn evolved from the BA.2.86 (Pirola) strain.These sub-lineages are known for their high transmissibility but relatively mild symptoms. Despite the rise, experts maintain that the current wave is manageable and no immediate threat of severe disease has been identified.Advisory To HospitalsIn an internal order, Delhi’s health department directed all hospitals to ensure critical equipment like ventilators, BiPAP machines, and oxygen concentrators are functional. Staff are being asked to undergo refresher training, and all hospitals must report Influenza-like Illness (ILI) and Severe Acute Respiratory Illness (SARI) cases daily on the Integrated Health Information Platform (IHIP).Additionally, 5% of ILI cases and 100% of SARI cases must undergo COVID-19 testing, in accordance with ICMR guidelines. Positive samples are to be sent to Lok Nayak Hospital for genome sequencing to detect any emerging variants.Neighboring States And Others Also Report Mild CasesHaryana: Two mild COVID-19 cases were reported in Gurgaon—a 62-year-old man and a 31-year-old woman who had recently travelled from Mumbai. Both are in home isolation. Meanwhile, a 28-year-old security guard from Faridabad tested positive at Delhi’s Safdarjung Hospital. None had a travel history abroad or known contact with infected persons. Health officials emphasized that these are isolated, mild cases and do not indicate a severe outbreak.Maharashtra: The state has reported 95 new COVID-19 cases in Mumbai this month, with a total of 106 since January. At least 16 patients are hospitalized, mostly shifted to Seven Hills Hospital from KEM Hospital. Pune, although not reporting any active cases currently, has reserved 50 beds at Naidu Hospital as a precautionary step.Tamil Nadu: In Chennai and Puducherry, health officials are seeing a shift in viral diagnosis, where fevers initially linked to influenza are now being identified as COVID-19. Public Health Director Dr. TS Selvavinayagam has urged caution in crowded places but reassured the public not to panic.Karnataka: The state currently has 16 active COVID-19 cases, confirmed by Health Minister Dinesh Gundu Rao.Gujarat: Seven new cases were reported in Ahmedabad in a single day—a sharp spike for a city that has averaged one case per month over the past year. All patients are in home isolation, and their samples have been sent for genomic sequencing. Officials say the infections are from the JN.1 variant and are mild in nature.International SpikeSingapore and Hong Kong are witnessing a noticeable surge in COVID-19 cases, primarily driven by LF.7 and NB.1.8 sub-variants. Singapore’s Ministry of Health has urged citizens to get vaccinated, especially those who haven’t received their initial doses. Hong Kong has reached its highest case numbers in over a year and is encouraging mask-wearing and crowd avoidance.What Are the Current Symptoms?Unlike earlier variants, the current wave presents some slightly different symptoms. While cough and sore throat remain common, additional symptoms include nausea, vomiting, brain fog, and conjunctivitis. Most cases are mild, but health authorities advise individuals to monitor symptoms and seek medical attention if needed.

FDA Greenlights Nucala as New Treatment for COPD

FDA approves Nucala as add-on therapy for COPD with high eosinophils, offering new hope by reducing flare-ups in patients unresponsive to inhaled treatments.

Health & Wellness

What Is ‘Ozempic Teeth’? Why ‘Ozempic Face’ Isn’t the Only Worry About the Weight-Loss Drug

what is ‘ozempic teeth’? why ‘ozempic face’ isn’t the only worry about the weight-loss drug

Dormant For 50 Years, Woman Dies From Extremely Rare Brain Disease Decades After Childhood Hormone Shot

dormant for 50 years, woman dies from extremely prion disease decades after childhood hormone shot

Nutrition

Salmonella Outbreak Linked To Florida-Grown Cucumbers, Warns CDC

salmonella outbreak linked to florida-grown cucumbers, warns cdc

The U.S. Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on maintenance treatment for adults with chronic obstructive pulmonary disease (<span>COPD</span>) that remains inadequately controlled despite existing therapies. The approval offers new hope to patients whose symptoms persist despite being on inhaled triple therapy.

According to the World Health Organization (WHO), COPD is a common, preventable, and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation due to airway and/or alveolar abnormalities. It typically results from significant exposure to noxious particles or gases.

<ul><li>Chronic cough</li><li>Shortness of breath</li><li>Wheezing</li><li>Chest tightness</li><li>Excess mucus production</li></ul>

Causes of COPD range from long-term smoking and air pollution exposure to occupational dusts and fumes. Genetics and respiratory infections in early life can also contribute.

COPD is progressive and often worsens over time, severely impacting quality of life. One of the most critical challenges in managing the condition is reducing exacerbations—flare-ups that may require hospitalization or emergency treatment.

Nucala is the only approved biologic that has been specifically studied in COPD patients with an eosinophilic phenotype defined by a blood eosinophil count (BEC) of ≥150 cells/μL. This is important because up to 70% of U.S. COPD patients who are not adequately managed on inhaled triple therapy fall into this category.

Biologics like Nucala work by targeting specific pathways in the immune system. Mepolizumab, the active ingredient in Nucala, is an anti-IL-5 monoclonal antibody that reduces eosinophilic inflammation—a key contributor to COPD exacerbations in certain patients.

The FDA’s approval of Nucala is based on results from two large Phase 3 clinical trials, MATINEE and METREX, which evaluated its use alongside optimal inhaled therapy. Both were randomized, double-blind, and placebo-controlled.

In the MATINEE trial, involving 804 patients with a BEC ≥300 cells/μL, Nucala showed:

A significant reduction in moderate or severe exacerbations: 0.80 vs 1.01 events/year (rate ratio, 0.79).

A 35% decrease in emergency visits or hospitalizations for COPD exacerbations (rate ratio, 0.65).

The METREX trial produced similar outcomes. Patients on Nucala had:

Fewer moderate or severe exacerbations: 1.40 vs 1.71 events/year (rate ratio, 0.82).

Adverse events were comparable between the Nucala and placebo groups, suggesting a favorable safety profile.

“COPD isn't just a disease, it's a relentless cycle,” said Dr. Jean Wright, CEO of the COPD Foundation. “Even with current therapies, managing exacerbations remains a daily battle. Biologics like mepolizumab offer new hope.”

The FDA approval was granted to GSK, the pharmaceutical company that developed Nucala. With this decision, clinicians now have a novel option for patients with eosinophilic COPD who are still struggling despite standard treatment.

us health news

copd

copd symptoms

copd drug approval

The U.S. Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on maintenance treatment for adults with chronic obstructive pulmonary disease (COPD) that remains inadequately controlled despite existing therapies. The approval offers new hope to patients whose symptoms persist despite being on inhaled triple therapy.What is COPD?According to the World Health Organization (WHO), COPD is a common, preventable, and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation due to airway and/or alveolar abnormalities. It typically results from significant exposure to noxious particles or gases.Symptoms of COPD include:Chronic coughShortness of breathWheezingChest tightnessExcess mucus productionCauses of COPD range from long-term smoking and air pollution exposure to occupational dusts and fumes. Genetics and respiratory infections in early life can also contribute.COPD is progressive and often worsens over time, severely impacting quality of life. One of the most critical challenges in managing the condition is reducing exacerbations—flare-ups that may require hospitalization or emergency treatment.Why Nucala MattersNucala is the only approved biologic that has been specifically studied in COPD patients with an eosinophilic phenotype defined by a blood eosinophil count (BEC) of ≥150 cells/μL. This is important because up to 70% of U.S. COPD patients who are not adequately managed on inhaled triple therapy fall into this category.Biologics like Nucala work by targeting specific pathways in the immune system. Mepolizumab, the active ingredient in Nucala, is an anti-IL-5 monoclonal antibody that reduces eosinophilic inflammation—a key contributor to COPD exacerbations in certain patients.Clinical Trial EvidenceThe FDA’s approval of Nucala is based on results from two large Phase 3 clinical trials, MATINEE and METREX, which evaluated its use alongside optimal inhaled therapy. Both were randomized, double-blind, and placebo-controlled.In the MATINEE trial, involving 804 patients with a BEC ≥300 cells/μL, Nucala showed:A significant reduction in moderate or severe exacerbations: 0.80 vs 1.01 events/year (rate ratio, 0.79).A 35% decrease in emergency visits or hospitalizations for COPD exacerbations (rate ratio, 0.65).The METREX trial produced similar outcomes. Patients on Nucala had:Fewer moderate or severe exacerbations: 1.40 vs 1.71 events/year (rate ratio, 0.82).Adverse events were comparable between the Nucala and placebo groups, suggesting a favorable safety profile.A New Era for COPD Management“COPD isn't just a disease, it's a relentless cycle,” said Dr. Jean Wright, CEO of the COPD Foundation. “Even with current therapies, managing exacerbations remains a daily battle. Biologics like mepolizumab offer new hope.”The FDA approval was granted to GSK, the pharmaceutical company that developed Nucala. With this decision, clinicians now have a novel option for patients with eosinophilic COPD who are still struggling despite standard treatment.

fda greenlights nucala as new treatment for copd

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

Delhi Air Pollution Is Also Causing Digestive Health Issues

Quick Stories

Nine-month-old Child Tested Positive For Covid-19 In Bengaluru

23 New Covid Cases In Delhi, Health Minister Issues Advisory

FDA Greenlights Nucala as New Treatment for COPD

Health Conditions A-Z

Nine-month-old Child Tested Positive For Covid-19 In Bengaluru

Postpartum Psychosis Is 10 Times More Likely For Women With Family Link To The Condition

Easy Ways To Control Your Blood Sugar And Morning Cravings